jueves, 28 de mayo de 2026
Safety and efficacy of allogeneic umbilical cord-derived mesenchymal stem cell infusion for frailty: a phase 2, single-centre, randomised, open-label controlled trial Liem T. Nguyena,b,e Send email to liem.nt@vinuni.edu.vn ∙ Kien T. Nguyena,e ∙ Lan T.M. Daoa,e ∙ Van T. Hoanga ∙ Trang T.K. Phana ∙ Nhung T.H. Dinha ∙ et al.
Safety and efficacy of allogeneic umbilical cord-derived mesenchymal stem cell infusion for frailty: a phase 2, single-centre, randomised, open-label controlled trial
Liem T. Nguyena,b,e Send email to liem.nt@vinuni.edu.vn ∙ Kien T. Nguyena,e ∙ Lan T.M. Daoa,e ∙ Van T. Hoanga ∙ Trang T.K. Phana ∙ Nhung T.H. Dinha ∙ et al.
https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(26)00150-7/fulltext?dgcid=hubspot_update_feature_updatealerts_ebiom&utm_campaign=update-ebiom&utm_medium=email&_hsenc=p2ANqtz--eN-PeSYMQzVYYXXrkjzFcoIRR6Cnnpqq4cP_TpoEPWSf8RfhuoOX-zmM-fDQKPZE7uQ-UGVcQrinK7qjMklwMRQANyg&_hsmi=420912456&utm_content=420560842&utm_source=hs_email
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario